Pacemakers By Guidant Have Flaw
Article Abstract:
Guidant Corp., which recently recalled thousands of implantable heart defibrillators, has just told doctors that nine of its older pacemaker models also have problems and should be replaced. The announcement of these product defects may affect Guidant's second quarter earnings, and it's planned acquisition by Johnson & Johnson.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
F.D.A. Says Flaws in Heart Devices Pose High Risks
Article Abstract:
Three implantable defibrillators, the Ventak Prizm 2 DR Model 1861, the Contak Renewal and the Contak Renewal 2, made by Guidant Corp. have been designated Class I recalls by the Food and Drug Administration. The implants have manufacturing defects that have caused the death of at least two patients.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Boston Scientific Widens Recall Of Stents for Heart Treatment
Article Abstract:
Boston Scientific Corporation's stock fell over three dollars, with the announcement of a voluntary recall of two of its heart stents. Company earnings reports for the second quarter have been delayed.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Many Are Surprised By Bold Decisions Of the Bush F.D.A. A Reminder That No Drug Is Risk-Free
- Abstracts: Shell Turns a Stock Page But Has Chapters to Go. Shell Warns Of New Cuts In Reserves Of Oil and Gas. Shell Weighs Modifying Dual Setup
- Abstracts: Paris Faulted On Aid Given To Telecom. Europe Is Said to Be Close To Allowing Bid by Oracle. Europe Puts More Limits On Bailouts Of Companies
- Abstracts: Mexican Retailers Unite Against Wal-Mart. Wal-Mart's next battlefield. Bankers Oppose Wal-Mart As Rival
- Abstracts: Third Executive Faces Complaint In Insurer Inquiry. As Investigations Stack Up, Aon May Be Next in the Cross Hairs